Connect with us

Abilify (aripiprazole)


Aripiprazole (or ABILIFY®) is mainly prescribed to treat schizophrenia, bipolar disorder, and major depressive disorder.

Status: ACTIVE

Class: Atypical (AAP)

FDA Approval: 2002

Dosage Forms: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg

Biological Half-life: 75 hours

Side Effects: Dizziness, nausea, orthostatic hypotension, constipation, headache, movement problems

Routes of Administration: Oral, Sublingual, IM, IV

Pregnancy Category: C (US)

  www.abilify.com

Advertisement

Twitter Feed

Major depression or bipolar disorder? EKG can help determine the correct diagnosis https://t.co/kq54tleJd9

Amazon might be eyeing the prescription drug market https://t.co/gLeIFjfj0u

Naloxone nasal spray as effective as injection for reversing opioid overdoses https://t.co/mZB2ld5uO8 #OpioidCrisis

Advertisement